from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3660c/-

LFCtreatmentdescriptionclass of inhibitor

-0.207

Amikacinug/mL Amikacintranslation

-0.354

Cap5-10ug/mL Capreomycintranslation

0.057

Rox10-50 ug/mL Roxithromycintranslation

-0.262

SM2-5 ug/mL Streptomycintranslation

0.318

Tet5-10 ug/mL Tetracyclinetranslation

-0.969

Rif0.2-5ug/mL Rifampicintranscription

-1.047

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.825

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.265

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.191

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.228

Clofazimine10-13 ug/mL Clofaziminerespiration

0.169

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.461

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.832

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.175

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.065

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.080

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.156

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.133

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.570

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.360

KCN5-20 ug/mL Potassium cyaniderespiration

0.911

NaN30.2-2 mM Sodium aziderespiration

-0.102

Nigericin50 uM Nigericinrespiration

-0.268

TRC10-150 ug/mL Triclosanrespiration

-0.201

TRZ10-25 ug/mL Thioridazinerespiration

1.412

Valinomycin0.5-10 uM Valinomycinrespiration

0.964

ZnSO42 mM ZnSO4respiration

1.159

menadione6-10 ug/mL Menadionerespiration

-0.178

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.041

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.403

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.065

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.068

NRP_1Non-replicating persistence stage 1dosRassociated

-0.266

Amp0.2mg/mL AmpicillincellWall

-0.049

Cephalexin20-100 ug/mL CephalexincellWall

-0.148

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.049

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.559

EMB10-20 ug/mL EthambutolcellWall

-0.462

Eta12-40 ug/mL EthionamidecellWall

-0.617

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.555

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.734

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.498

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.087

BZA0.12 mg/mL BenzamidearomaticAmides

0.098

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.208

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.730

H2O24 mM hydrogen peroxideDNAdamaging

2.329

Levo10 ug/mL LevofloxacinDNAdamaging

-1.076

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.723

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.102

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.140

UVUV-irradiationDNAdamaging

0.894

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.123

Antimycin12.5-50 ug/mL Antimycin A?

-0.258

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.321

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.290

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.974

PA8240.2-2 ug/mL PA-824?

0.320

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.080

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.085

Verapamil50 uM Verapamil?

0.128

mercaptoethanol2 mM 2-Mercaptoethanol?

0.182

methoxatin10-20 ug/mL Methoxatin?